465 related articles for article (PubMed ID: 22409371)
1. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.
Perera PN; Armstrong EP; Sherrill DL; Skrepnek GH
COPD; 2012 Apr; 9(2):131-41. PubMed ID: 22409371
[TBL] [Abstract][Full Text] [Related]
2. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
3. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.
Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP
J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease.
Chen YH; Yao WZ; Cai BQ; Wang H; Deng XM; Gao HL; Huang JS; Wang XM
Chin Med J (Engl); 2008 Apr; 121(7):587-91. PubMed ID: 18466676
[TBL] [Abstract][Full Text] [Related]
5. [Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer].
Zhu ML; Cai BQ
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):258-61. PubMed ID: 19576037
[TBL] [Abstract][Full Text] [Related]
6. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
Moll K; Sun SX; Ellis JJ; Howe A; Amin A
Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
[TBL] [Abstract][Full Text] [Related]
7. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
8. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease.
Patil SP; Krishnan JA; Lechtzin N; Diette GB
Arch Intern Med; 2003 May; 163(10):1180-6. PubMed ID: 12767954
[TBL] [Abstract][Full Text] [Related]
9. Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States.
Zilberberg MD; Luippold RS; Sulsky S; Shorr AF
Crit Care Med; 2008 Mar; 36(3):724-30. PubMed ID: 18209667
[TBL] [Abstract][Full Text] [Related]
10. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.
Dalal AA; Shah M; Lunacsek O; Hanania NA
Respir Med; 2011 Oct; 105(10):1516-22. PubMed ID: 21684731
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
14. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters.
Stein BD; Charbeneau JT; Lee TA; Schumock GT; Lindenauer PK; Bautista A; Lauderdale DS; Naureckas ET; Krishnan JA
COPD; 2010 Jun; 7(3):164-71. PubMed ID: 20486814
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
16. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
17. [Cost analysis for inpatient therapy for patients with acute exacerbations of chronic obstructive pulmonary disease].
Motegi T; Yamada K; Kida K
Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):787-94. PubMed ID: 17144574
[TBL] [Abstract][Full Text] [Related]
18. Discharge dispositions, complications, and costs of hospitalization in spinal cord tumor surgery: analysis of data from the United States Nationwide Inpatient Sample, 2003-2010.
Sharma M; Sonig A; Ambekar S; Nanda A
J Neurosurg Spine; 2014 Feb; 20(2):125-41. PubMed ID: 24286530
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
20. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
Singh JA; Yu S
Respir Res; 2016 Jan; 17():1. PubMed ID: 26739476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]